Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors

被引:50
|
作者
Alashek, Wiam A. [1 ]
McIntyre, Christopher W. [1 ,2 ]
Taal, Maarten W. [2 ]
机构
[1] Univ Nottingham, Sch Grad Entry Med, Nottingham NG7 2RD, England
[2] Derby Hosp NHS Fdn Trust, Dept Renal Med, Derby, England
来源
BMC INFECTIOUS DISEASES | 2012年 / 12卷
关键词
Haemodialysis; Hepatitis B; Hepatitis C; Incidence; Libya; Nosocomial infection; Prevalence; VIRUS-INFECTION; BLOOD-TRANSFUSIONS; MOLECULAR EVIDENCE; DIALYSIS PATIENTS; LIVER-DISEASE; CONTINENTS; UNITS; POPULATION; SEROCONVERSION; EPIDEMIOLOGY;
D O I
10.1186/1471-2334-12-265
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Patients receiving maintenance haemodialysis (HD) are at higher risk for acquiring Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) infections than the general population. Strict infection control measures are essential to prevent nosocomial transmission. We aimed to investigate the incidence and prevalence of HBV and HCV infection in the HD population of Libya as well as risk factors for infection. Methods: All adult patients receiving maintenance HD (n=2382) in Libyan dialysis centres (n=39) were studied between May 2009 and October 2010. Testing for Hepatitis B surface antigen (HBsAg) and anti-HCV antibodies was performed at initiation of dialysis and every 3-6 months thereafter. Patients who were sero-negative for HBV and HCV (n=1160) were followed up for 1 year to detect sero-conversions. Results: Participant median age was 49 years and 58% were male. 831 patients (34.9%) were sero-positive for HBV and/or HCV (anti-HCV positive 31.1%; HBsAg positive 2.6%; both positive 1.2%). Of the sero-positive patients 4.7% were known to be infected before the initiation of HD. The prevalence of HBV +/- HCV infection varied widely between HD centres from 0% to 75.9%. Sero-positive patients were younger, had longer time on dialysis and more previous blood transfusions. Prospective follow-up revealed an incidence of sero-conversion of 7.7% during 1 year (7.1% HCV; 0.6% HBV). Wide variation in rates of newly acquired infections was observed between dialysis centres. All new HBV cases were referred from centres already treating HBV infected patients. New HCV infections were reported in most centres but the rate of HCV sero-conversion varied widely from 1.5% to 31%. Duration of dialysis, history of previous renal transplant and history of receiving HD in another centre in Libya were significantly associated with sero-conversion. Conclusion: Patients on maintenance HD in Libya have a high incidence and prevalence of HCV infection and lower rates of HBV infection. The factors associated with HBV and HCV infection are highly suggestive of nosocomial transmission within HD units. Urgent action is required to improve infection control measures in HD centres and to reduce dependence on blood transfusions for the treatment of anaemia.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors
    Wiam A Alashek
    Christopher W McIntyre
    Maarten W Taal
    BMC Infectious Diseases, 12
  • [2] Incidence and risk factors of hepatitis C virus infection in a haemodialysis unit
    Forns, X
    FernandezLlama, P
    Pons, M
    Costa, J
    Ampurdanes, S
    LopezLabrador, FX
    Olmedo, E
    LopezPedret, J
    Darnell, A
    Revert, L
    SanchezTapias, JM
    Rodes, J
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (04) : 736 - 740
  • [3] Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients
    Jadoul, Michel
    Bieber, Brian A.
    Martin, Paul
    Akiba, Takashi
    Nwankwo, Chizoba
    Arduino, Jean Marie
    Goodkin, David A.
    Pisoni, Ronald L.
    KIDNEY INTERNATIONAL, 2019, 95 (04) : 939 - 947
  • [4] Prevalence of hepatitis C virus infection and related risk factors among Iranian haemodialysis patients
    Alavian, SM
    Einollahi, B
    Hajarizadeh, B
    Bakhtiari, S
    Nafar, M
    Ahrabi, S
    NEPHROLOGY, 2003, 8 (05) : 256 - 260
  • [5] Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients:: a multicentre study in 2796 patients
    Hinrichsen, H
    Leimenstoll, G
    Stegen, G
    Schrader, H
    Fölsch, UR
    Schmidt, WE
    GUT, 2002, 51 (03) : 429 - 433
  • [6] Prevalence of hepatitis B and hepatitis C in haemodialysis patients
    Santos, MG
    Danguilan, RA
    Que, ET
    Balmaceda, RP
    Padilla, BS
    NEPHROLOGY, 1998, 4 (1-2) : 101 - 104
  • [7] Prevalence and risk factors of hepatitis B and C viruses among haemodialysis patients: a multicentric study
    Ali, Niyaz
    Hussain, Wajid
    Hayat, Azam
    Shah, Tariq
    Wen, Ronghui
    Zeb, Ifra
    Malik, Attiya Abdul
    Ramzan, Rahdia
    Mujaddad-ur Rehman
    Khan, Ibrar
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (01) : 29 - 33
  • [8] PREVALENCE AND RISK FACTORS OF HEPATITIS C VIRUS INFECTION IN HAEMODIALYSIS PATIENTS: TESTING ANTIBODIES, RNA AND GENOTYPES
    Al-Kubaisy, Waqar
    Noor, Nor Aini Mohd
    Ibrahim, Nik Shamsidah Nik
    Al-Nasirie, Usama
    JURNAL TEKNOLOGI, 2015, 77 (25): : 115 - 119
  • [9] Prevalence and risk factors of hepatitis B and C viruses among haemodialysis patients in Gaza strip, Palestine
    El-Ottol, Abed El-Kader Y.
    Elmanama, Abdelraouf A.
    Ayesh, Basim M.
    VIROLOGY JOURNAL, 2010, 7
  • [10] Prevalence and risk factors of hepatitis B and C viruses among haemodialysis patients in Gaza strip, Palestine
    Abed El-kader Y El-Ottol
    Abdelraouf A Elmanama
    Basim M Ayesh
    Virology Journal, 7